ISLB 2025 : ScreenCell® at the 7th Annual Liquid Biopsy Conference in Orlando
From November 1st to 3rd, 2025, ScreenCell® will be crossing the Atlantic to Orlando, Florida, for the 7th Annual Liquid Biopsy Conference (ISLB 2025). Dr. Sina Naserian, our Chief Technology Officer, will represent the company at this unmissable international gathering that brings together global excellence in liquid biopsy.
ScreenCell® to attend ESLB 2025 General Assembly in Madrid
ScreenCell® will be present in Madrid on November 3 and 4, 2025 for the 2025 General Assembly of the European Society of Liquid Biopsy (ESLB). Our Chief Scientific Officer, Dr. Georges Uzan, will represent the company at this major event, which will bring together Europe’s leading liquid biopsy experts.
Meet ScreenCell® at the ACTC 2025 (7th Advances in Circulating Tumor Cells Meeting)
ScreenCell will attend the 7th Advances in Circulating Tumor Cells Meeting (ACTC 2025) in Thessaloniki, Greece, as a Gold sponsor and exhibitor. Join us from September 24–27 to explore our latest innovations in circulating tumor cells (CTCs) and meet our team!
2nd IBC-IC in Africa: Discover the Power of ScreenCell® Technology
Discover ScreenCell® Technology at the 2nd IBC-IC (Inflammatory Breast Cancer International Consortium) in Africa and the 8th Ariana’s OncoDay. These events will take place on May 9th and 10th, 2025, at the Carthage Thalasso Resort Hotel in Tunis, Tunisia.
ISMRC 2025: Join ScreenCell to Discover Our CTC Isolation Method
We are excited to announce that ScreenCell will be attending the upcoming edition of the International Symposium on Minimal Residual Cancer (ISMRC), which will take place over three days from May 7 to 9, 2025, in Nice, France.
ScreenCell at SIMEM 2025: Meet us on the Genethical® stand
ScreenCell will be exhibiting at SIMEM 2025 in Oran from April 9 to 12 at the Genethical booth. Come discover our innovative solutions for analyzing circulating tumor cells and talk to our experts!